🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare 6-month treatment outcomes for 15-2...
Status
Completed
Location
Friends Research Institute
Start Date
2013-06
Trial ID
NCT01843023
Treatments Being Tested
This study is a phase IV, two-arm, randomized, double-blind, placebo-contro...
Status
Recruiting
Location
University of Pennsylvania Center for Studies of Addiction
Start Date
2022-03-07
Trial ID
NCT05028062
Treatments Being Tested
This is an 8-week, double-blind, randomized placebo-controlled trial of the...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2023-04-18
Trial ID
NCT05262270
The aim of this study is to investigate the safety and effectiveness of bup...
Status
Completed
Location
UCLA Integrated Substance Abuse Programs (ISAP)
Start Date
2011-09
Trial ID
NCT01402492
Treatments Being Tested
This study will recruit 159 HIV-infected men with alcohol use disorders (AU...
Status
Completed
Location
Asociación Civil Impacta Salud y Educación
Start Date
2014-05
Trial ID
NCT01377168
Treatments Being Tested
This study seeks to compare the effectiveness of two medications used to tr...
Status
Completed
Location
Yale University School of Medicine
Start Date
2021-01-07
Trial ID
NCT04219540
Treatments Being Tested
The Primary Objective of this study is to compare the effectiveness of HIV ...
Status
Completed
Location
Tarzana Treatment Centers
Start Date
2018-02-05
Trial ID
NCT03275350
Treatments Being Tested
Naltrexone is a medication that has been shown to help prevent relapse to o...
Status
Completed
Location
Rhode Island Hospital
Start Date
2012-03
Trial ID
NCT01563718
Treatments Being Tested
This is a double-blind placebo-controlled study to evaluate the effect of N...
Status
Completed
Location
Yale University School of Medicine
Start Date
2011-04
Trial ID
NCT01227044
Treatments Being Tested
Extended-release naltrexone (XR-NTX, VIVITROL) is an FDA-approved medicatio...
Status
Completed
Location
Substance Use Research Unit
Start Date
2012-09
Trial ID
NCT01449565
Treatments Being Tested